PT1128829E - Associacao de riluzole e de alfa-tocoferol - Google Patents

Associacao de riluzole e de alfa-tocoferol

Info

Publication number: PT1128829E
Authority: PT; Portugal
Prior art keywords: riluzole; associacao; tocoferol; alfa; combination
Prior art date: 1998-11-13

Application number

PT99972101T

Other languages

English (en)

Inventor

Michel Dib

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-13

Filing date

1999-11-09

Publication date

2005-07-29

1999-11-09 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2005-07-29 Publication of PT1128829E publication Critical patent/PT1128829E/pt

Links

FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 3
229960004181 riluzole Drugs 0.000 title abstract 2
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
229940087168 alpha tocopherol Drugs 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229960000984 tocofersolan Drugs 0.000 abstract 1
239000002076 α-tocopherol Substances 0.000 abstract 1
235000004835 α-tocopherol Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)
External Artificial Organs (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Anti-Oxidant Or Stabilizer Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Plural Heterocyclic Compounds (AREA)
Saccharide Compounds (AREA)
Pyrane Compounds (AREA)
Cosmetics (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)

PT99972101T 1998-11-13 1999-11-09 Associacao de riluzole e de alfa-tocoferol PT1128829E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9814250A FR2785808B1 (fr)	1998-11-13	1998-11-13	Association riluzole et alpha-tocopherol

Publications (1)

Publication Number	Publication Date
PT1128829E true PT1128829E (pt)	2005-07-29

Family

ID=9532674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99972101T PT1128829E (pt)	1998-11-13	1999-11-09	Associacao de riluzole e de alfa-tocoferol

Country Status (23)

Country	Link
US (2)	US6642262B2 (pt)
EP (1)	EP1128829B1 (pt)
JP (1)	JP4693241B2 (pt)
KR (1)	KR100641472B1 (pt)
CN (1)	CN1177587C (pt)
AT (1)	ATE295168T1 (pt)
AU (1)	AU776242B2 (pt)
BR (1)	BR9915292A (pt)
CA (1)	CA2350671C (pt)
CZ (1)	CZ298808B6 (pt)
DE (1)	DE69925301T2 (pt)
DK (1)	DK1128829T3 (pt)
EA (1)	EA003671B1 (pt)
ES (1)	ES2239858T3 (pt)
FR (1)	FR2785808B1 (pt)
HK (1)	HK1041220B (pt)
HU (1)	HU226067B1 (pt)
IL (1)	IL142708A0 (pt)
NO (1)	NO328349B1 (pt)
PT (1)	PT1128829E (pt)
TR (1)	TR200101346T2 (pt)
WO (1)	WO2000028992A1 (pt)
ZA (1)	ZA200103810B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786101B1 (fr) *	1998-11-24	2002-07-05	Aventis Laboratoire	Utilisation de la nicergoline dans le traitement de la spasticite
CA2625341A1 (en) *	2005-10-18	2007-04-26	Ono Pharmaceutical Co., Ltd.	Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
US20070099156A1 (en) *	2005-10-28	2007-05-03	Jeff Wagner	Self-etching dental primer compositions and methods and systems utilizing such compositions
FR2957077B1 (fr) *	2010-03-02	2012-04-13	Univ Dauvergne Clermont I	Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
WO2014145776A2 (en) *	2013-03-15	2014-09-18	Baylor College Of Medicine	Msp and its receptors in the therapy of amyotrophic lateral sclerosis
CN114344297B (zh) *	2022-03-01	2024-05-14	暨南大学	利鲁唑在治疗少精症中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2688138B1 (fr) *	1992-03-06	1995-05-05	Rhone Poulenc Rorer Sa	Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US5843641A (en) *	1993-02-26	1998-12-01	Massachusetts Institute Of Technology	Methods for the daignosis, of familial amyotrophic lateral sclerosis
US6380252B1 (en) *	1996-07-05	2002-04-30	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5780489A (en) *	1996-08-21	1998-07-14	Brooks; Benjamin Rix	Method for treating amyotrophic lateral sclerosis
JP3889844B2 (ja) *	1997-02-10	2007-03-07	龍兒梶	筋萎縮性側索硬化症治療剤
FR2782008B1 (fr) *	1998-08-07	2003-04-25	Sod Conseils Rech Applic	Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

1998
- 1998-11-13 FR FR9814250A patent/FR2785808B1/fr not_active Expired - Fee Related
1999
- 1999-11-09 BR BR9915292-4A patent/BR9915292A/pt not_active Application Discontinuation
- 1999-11-09 DE DE69925301T patent/DE69925301T2/de not_active Expired - Lifetime
- 1999-11-09 ES ES99972101T patent/ES2239858T3/es not_active Expired - Lifetime
- 1999-11-09 KR KR1020017005912A patent/KR100641472B1/ko not_active Expired - Fee Related
- 1999-11-09 JP JP2000582039A patent/JP4693241B2/ja not_active Expired - Fee Related
- 1999-11-09 HK HK02102998.6A patent/HK1041220B/zh not_active IP Right Cessation
- 1999-11-09 IL IL14270899A patent/IL142708A0/xx not_active IP Right Cessation
- 1999-11-09 HU HU0105301A patent/HU226067B1/hu not_active IP Right Cessation
- 1999-11-09 EA EA200100530A patent/EA003671B1/ru not_active IP Right Cessation
- 1999-11-09 WO PCT/FR1999/002753 patent/WO2000028992A1/fr not_active Ceased
- 1999-11-09 DK DK99972101T patent/DK1128829T3/da active
- 1999-11-09 AU AU11655/00A patent/AU776242B2/en not_active Ceased
- 1999-11-09 CN CNB998131903A patent/CN1177587C/zh not_active Expired - Fee Related
- 1999-11-09 CZ CZ20011561A patent/CZ298808B6/cs not_active IP Right Cessation
- 1999-11-09 EP EP99972101A patent/EP1128829B1/fr not_active Expired - Lifetime
- 1999-11-09 PT PT99972101T patent/PT1128829E/pt unknown
- 1999-11-09 CA CA2350671A patent/CA2350671C/fr not_active Expired - Fee Related
- 1999-11-09 AT AT99972101T patent/ATE295168T1/de active
- 1999-11-09 TR TR2001/01346T patent/TR200101346T2/xx unknown
2001
- 2001-05-10 ZA ZA200103810A patent/ZA200103810B/en unknown
- 2001-05-10 NO NO20012308A patent/NO328349B1/no not_active IP Right Cessation
- 2001-05-11 US US09/854,318 patent/US6642262B2/en not_active Expired - Lifetime
2003
- 2003-02-18 US US10/369,151 patent/US20030125363A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1041220A1 (en)	2002-07-05
ATE295168T1 (de)	2005-05-15
FR2785808A1 (fr)	2000-05-19
HUP0105301A2 (hu)	2002-05-29
NO20012308L (no)	2001-05-10
KR20010080407A (ko)	2001-08-22
AU1165500A (en)	2000-06-05
EA003671B1 (ru)	2003-08-28
TR200101346T2 (tr)	2002-05-21
WO2000028992A1 (fr)	2000-05-25
HK1041220B (zh)	2005-07-22
ES2239858T3 (es)	2005-10-01
EA200100530A1 (ru)	2001-10-22
NO20012308D0 (no)	2001-05-10
NO328349B1 (no)	2010-02-01
US6642262B2 (en)	2003-11-04
KR100641472B1 (ko)	2006-10-31
EP1128829B1 (fr)	2005-05-11
BR9915292A (pt)	2001-08-07
IL142708A0 (en)	2002-03-10
CN1177587C (zh)	2004-12-01
US20030125363A1 (en)	2003-07-03
DE69925301D1 (de)	2005-06-16
CZ20011561A3 (cs)	2001-08-15
AU776242B2 (en)	2004-09-02
DK1128829T3 (da)	2005-08-29
DE69925301T2 (de)	2006-01-26
JP4693241B2 (ja)	2011-06-01
CZ298808B6 (cs)	2008-02-06
ZA200103810B (en)	2002-08-12
JP2002529506A (ja)	2002-09-10
CA2350671C (fr)	2010-05-04
CA2350671A1 (fr)	2000-05-25
EP1128829A1 (fr)	2001-09-05
US20020019426A1 (en)	2002-02-14
FR2785808B1 (fr)	2002-12-06
HU226067B1 (en)	2008-04-28
CN1326348A (zh)	2001-12-12
HUP0105301A3 (en)	2006-07-28

Publication	Publication Date	Title
DK1214936T3 (da)	2004-12-06	Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
ES2114487B1 (es)	1999-04-01	Mezcla estabilizante sinergistica.
UA34466C2 (uk)	2001-03-15	Засіб для несистемної боротьби з паразитуючими комахами
BR0215405A (pt)	2005-01-25	Composições e processos de uso de collajolie
BRPI0412684A (pt)	2006-10-03	compostos ppar-ativos
ES2138691T3 (es)	2000-01-16	Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ITRM940150A0 (it)	1994-03-18	Procedimento per il trattamento di acque di scarico fortemente colorate.
TR199901191T2 (xx)	1999-12-21	Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
DK0804421T3 (da)	1999-03-01	2-((Dihydro)pyrazolyl-3'-oxymethylen)-anilider som skadedyrsbekæmpelsesmidler og fungicider
NO954427D0 (no)	1995-11-06	Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
PT1193270E (pt)	2003-10-31	Pirrolobenzodiazepinas
DK1336605T3 (da)	2006-06-19	Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X
FR2848116B1 (fr)	2007-01-05	Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
PT1119359E (pt)	2004-08-31	Formulacao de 2-metil-tieno-benzodiazepina
BR9608594B1 (pt)	2010-07-27	misturas de benzimidazóis substituìdos para o combate de protozoários parasìticos.
PT941975E (pt)	2002-06-28	Cimento para injeccao contendo inibidores de corrosao
IS5951A (is)	2001-05-22	5HT1 mótlyf fyrir meðferð gegn þunglyndi
FR2785808B1 (fr)	2002-12-06	Association riluzole et alpha-tocopherol
AU2002218337A1 (en)	2002-06-11	Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives
DE60121048D1 (de)	2006-08-03	PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DK1073447T3 (da)	2007-09-03	N1-modificerede glycopeptider
UY26574A1 (es)	2001-04-30	" procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
MY140504A (en)	2009-12-31	Statin-mmp inhibitor combinations
SE9602416D0 (sv)	1996-06-18	New forms of an organic salt of N'N-diacetylcystine
BR0307352A (pt)	2004-12-14	Processos para a preparação de um composto e para a preparação de propionato de fluticasona, composto, e, processo para a preparação de um sal de imidazol do composto